Response to comment on "PuraStat for gastrointestinal bleeding management: Effective approach for endoscopic prevention and rescue therapy"
Roberta Maselli, Leonardo Da Rio, Cesare Hassan, Alessandro Repici
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGastrointestinal Bleeding Diagnosis and Treatment
We thank Dr. Merola and colleagues for the thoughtful commentary about our study regarding use of PuraStat in endoscopic management and prevention of gastrointestinal bleeding. We appreciate the valuable insights shared, particularly the agreement with the potential of PuraStat for both managing active “oozing” bleeding and preventing delayed rebleeding.
Regarding the five cases of severe active bleeding discussed in our manuscript, we can provide some additional details to clarify management of these cases. Specifically:
As indicated in the manuscript, PuraStat was used as a secondary treatment in these cases, alongside other hemostatic techniques, primarily to prevent delayed rebleeding and ensure technical success. We recognize the importance of further clarifying the characteristics of the active gastrointestinal bleeding lesions most likely to benefit from PuraStat and agree that additional data would be valuable. Furthermore, we concur with the observation that prospective comparative studies will be essential for establishing the definitive role of PuraStat in bleeding control, as well as its impact on clinical outcomes such as hospitalization length, morbidity, and mortality rates.
Publication noteLetters to the editor do not necessarily represent the opinion of the editor or publisher. The editor and publisher reserve the right to not publish letters to the editor, or to publish them abbreviated or in extracts.